120 related articles for article (PubMed ID: 37696194)
21. Diagnostic yield and treatment impact of whole-genome sequencing in paediatric neurological disorders.
Lee HF; Chi CS; Tsai CR
Dev Med Child Neurol; 2021 Aug; 63(8):934-938. PubMed ID: 33244750
[TBL] [Abstract][Full Text] [Related]
22. Practices and views of neurologists regarding the use of whole-genome sequencing in clinical settings: a web-based survey.
Jaitovich Groisman I; Hurlimann T; Shoham A; Godard B
Eur J Hum Genet; 2017 Jun; 25(7):801-808. PubMed ID: 28488681
[TBL] [Abstract][Full Text] [Related]
23. Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinants.
Symonds JD; Elliott KS; Shetty J; Armstrong M; Brunklaus A; Cutcutache I; Diver LA; Dorris L; Gardiner S; Jollands A; Joss S; Kirkpatrick M; McLellan A; MacLeod S; O'Regan M; Page M; Pilley E; Pilz DT; Stephen E; Stewart K; Ashrafian H; Knight JC; Zuberi SM
Brain; 2021 Oct; 144(9):2879-2891. PubMed ID: 34687210
[TBL] [Abstract][Full Text] [Related]
24. The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer.
Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P
BMC Cancer; 2018 Apr; 18(1):454. PubMed ID: 29685123
[TBL] [Abstract][Full Text] [Related]
25. Overcoming challenges to meaningful informed consent for whole genome sequencing in pediatric cancer research.
Oberg JA; Glade Bender JL; Cohn EG; Morris M; Ruiz J; Chung WK; Appelbaum PS; Kung AL; Levine JM
Pediatr Blood Cancer; 2015 Aug; 62(8):1374-80. PubMed ID: 25832998
[TBL] [Abstract][Full Text] [Related]
26. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
27. Exploring the genetic etiology of drug-resistant epilepsy: incorporation of exome sequencing into practice.
Mahdiannasser M; Rashidi-Nezhad A; Badv RS; Akrami SM
Acta Neurol Belg; 2022 Dec; 122(6):1457-1468. PubMed ID: 36127562
[TBL] [Abstract][Full Text] [Related]
28. A Systems Biology Approach for Personalized Medicine in Refractory Epilepsy.
Naimo GD; Guarnaccia M; Sprovieri T; Ungaro C; Conforti FL; Andò S; Cavallaro S
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366017
[TBL] [Abstract][Full Text] [Related]
29. Next-generation sequencing improves treatment efficacy and reduces hospitalization in children with drug-resistant epilepsy.
Peng J; Pang N; Wang Y; Wang XL; Chen J; Xiong J; Peng P; Zhu CH; Kessi MB; He F; Yin F
CNS Neurosci Ther; 2019 Jan; 25(1):14-20. PubMed ID: 29933521
[TBL] [Abstract][Full Text] [Related]
30. Motivations, concerns and preferences of personal genome sequencing research participants: Baseline findings from the HealthSeq project.
Sanderson SC; Linderman MD; Suckiel SA; Diaz GA; Zinberg RE; Ferryman K; Wasserstein M; Kasarskis A; Schadt EE
Eur J Hum Genet; 2016 Jan; 24(1):14-20. PubMed ID: 26036856
[TBL] [Abstract][Full Text] [Related]
31. The role of targeted gene panel in pediatric drug-resistant epilepsy.
Wu CC; Tsai MH; Chu YJ; Weng WC; Fan PC; Lee WT
Epilepsy Behav; 2020 May; 106():107003. PubMed ID: 32169601
[TBL] [Abstract][Full Text] [Related]
32. Public attitudes in Japan toward participation in whole genome sequencing studies.
Okita T; Ohashi N; Kabata D; Shintani A; Kato K
Hum Genomics; 2018 Apr; 12(1):21. PubMed ID: 29653595
[TBL] [Abstract][Full Text] [Related]
33. The genomic landscape across 474 surgically accessible epileptogenic human brain lesions.
López-Rivera JA; Leu C; Macnee M; Khoury J; Hoffmann L; Coras R; Kobow K; Bhattarai N; Pérez-Palma E; Hamer H; Brandner S; Rössler K; Bien CG; Kalbhenn T; Pieper T; Hartlieb T; Butler E; Genovese G; Becker K; Altmüller J; Niestroj LM; Ferguson L; Busch RM; Nürnberg P; Najm I; Blümcke I; Lal D
Brain; 2023 Apr; 146(4):1342-1356. PubMed ID: 36226386
[TBL] [Abstract][Full Text] [Related]
34. Personal genomic screening: How best to facilitate preparedness of future clients.
Fleming J; Terrill B; Dziadek M; Kirk EP; Roscioli T; Barlow-Stewart K
Eur J Med Genet; 2019 May; 62(5):397-404. PubMed ID: 31085343
[TBL] [Abstract][Full Text] [Related]
35. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
Rees S; Williams A
JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
[TBL] [Abstract][Full Text] [Related]
36. Determinants of health and wellbeing in refractory epilepsy and surgery: The Patient Reported, ImpleMentation sciEnce (PRIME) model.
Rapport F; Shih P; Faris M; Nikpour A; Herkes G; Bleasel A; Kerr M; Clay-Williams R; Mumford V; Braithwaite J
Epilepsy Behav; 2019 Mar; 92():79-89. PubMed ID: 30634157
[TBL] [Abstract][Full Text] [Related]
37. Simulating the Genetics Clinic of the Future - whether undergoing whole-genome sequencing shapes professional attitudes.
Brunfeldt M; Teare H; Schuurbiers D; Steinberger D; Gerrits E; Vornanen M; Knoers N; Kääriäinen H; Vrijenhoek T
J Community Genet; 2022 Apr; 13(2):247-256. PubMed ID: 35084702
[TBL] [Abstract][Full Text] [Related]
38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
39. Advances in genetic testing and optimization of clinical management in children and adults with epilepsy.
Scala M; Bianchi A; Bisulli F; Coppola A; Elia M; Trivisano M; Pruna D; Pippucci T; Canafoglia L; Lattanzi S; Franceschetti S; Nobile C; Gambardella A; Michelucci R; Zara F; Striano P
Expert Rev Neurother; 2020 Mar; 20(3):251-269. PubMed ID: 31941393
[No Abstract] [Full Text] [Related]
40. Early technology assessment of using whole genome sequencing in personalized oncology.
Simons M; Van De Ven M; Coupé V; Joore M; IJzerman M; Koffijberg E; Frederix G; Uyl-De Groot C; Cuppen E; Van Harten W; Retèl V
Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):343-351. PubMed ID: 33910430
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
